Study of dengue virus infection in SCID mice engrafted with human K562 cells

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9729-9737

  Lin, Yi Ling ^a,b   Liao, Ching Len ^a   Chen, Li Kuang ^a   Yeh, Chia Tsui ^a   Liu, Chiu I ^a   Ma, Shiou Hwa ^a   Huang, Yu Ying ^a   Huang, Yue Ling ^a   Kao, Chuan Liang ^a   King, Chwan Chuen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL STRAIN K 562; DENGUE; HUMAN; HUMAN CELL; MORTALITY; MOUSE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SCID MOUSE; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0031774380     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9729-9737.1998     Document Type: Article

References (45)

1. Akarid, K., M. Sinet, B. Desforges, and M. A. Gougerot-Pocidalo. 1995. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69:7001-7005.
2. Amano, T., E. Richelson, and M. Nirenberg. 1972. Neurotransmitter synthesis by neuroblastoma clones. Proc. Natl. Acad. Sci. USA 69:258-263.
3. Amor, S., M. F. Scallan, M. M. Morris, H. Dyson, and J. K. Fazakerley. 1996. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J. Gen. Virol. 77:281-291.
4. Bi, Z., and C. S. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
5. Boonpucknavig, S., O. Vuttiviroj, and V. Boonpucknavig. 1981. Infection of young adult mice with dengue virus type 2. Trans. R. Soc. Trop. Med. Hyg. 75:647-653.
6. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
7. Brandt, W. E., J. M. McCown, M. K. Gentry, and P. K. Russell. 1982. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect. Immun. 36:1036-1041.
8. Chambers, T. J., C. S. Hahn, R. Galler, and C. M. Rice. 1990. Flavivirus genome, organization, expression, and replication. Annu. Rev. Microbiol. 44:649-688.
9. Chen, L.-K., C.-L. Liao, C.-G. Lin, S.-C. Lai, C.-I. Liu, S.-H. Ma, Y.-Y. Huang, and Y.-L. Lin. 1996. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology 217:220-229.
10. Chen, L.-K., Y.-L. Lin, C.-L. Liao, C.-G. Lin, Y.-L. Huang, C.-T. Yeh, S.-C. Lai, J.-T. Jan, and C. Chin. 1996. Generation and characterization of organtropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology 223:79-88.
11. Croen, K. D. 1993. Evidence for antiviral effect of nitric oxide: inhibition of herpes simplex virus type-1 replication. J. Clin. Investig. 91:2446-2452.
12. Feuer, G., S. A. Stewart, S. M. Baird, F. Lee, R. Feuer, and I. S. Chen. 1995. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J. Virol. 69:1328-1333.
13. Gubler, D. J. 1994. Dengue viruses, p. 324-331. In R. G. Webster and A. Granoff (ed.), Encyclopedia of virology. Academic Press, Inc., San Diego, Calif.
14. Halevy, M., Y. Akov, D. Ben-Nathan, D. Kobiler, B. Lachmi, and S. Lustig. 1994. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch. Virol. 137: 355-370.
15. Halstead, S. B., and E. J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:201-217.
16. Halstead, S. B. 1979. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140:527-533.
17. Halstead, S. B., C. N. Venkateshan, M. K. Gentry, and L. K. Larsen. 1984. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 132:1529-1532.
18. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
19. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11:S830-S839.
20. Harris, N., R. M. Buller, and G. Karupiah. 1995. Gamma interferon-induced nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69: 910-915.
21. Karupiah, G., Q. W. Xie, R. M. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445-1448.
22. Kohler, G., and C. Milstein. 1976. Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur. J. Immunol. 6:511-519.
23. Kurane, I., B. L. Innis, S. Nimmannitya, A. Nisalak, A. L. Rothman, P. G. Livingston, J. Janus, and F. A. Ennis. 1990. Human immune responses to dengue viruses. Southeast Asian J. Trop. Med. Public Health 21:658-662.
24. Kurane, I., U. Kontny, J. Janus, and F. A. Ennis. 1990. Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infection. Arch. Virol. 110:91-101.
25. Kurane, I., and F. A. Ennis. 1992. Immunity and immunopathology in dengue virus infections. Semin. Immunol. 4:121-127.
26. Lin, Y.-L., Y.-L. Huang, S.-H. Ma, C.-T. Yeh, S.-Y. Chiou, L.-K. Chen, and C.-L. Liao. 1997. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 71:5227-5235.
27. Littaua, R., I. Kurane, and F. A. Ennis. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 144:3183-3186.
28. Lozzio, B. B., C. B. Lozzio, E. G. Bamberger, and A. S. Feliu. 1981. A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166:546-550.
29. Lum, L. C., S. K. Lam, Y. S. Choy, R. George, and F. Harum. 1996. Dengue encephalitis: a true entity? Am. J. Trop. Med. Hyg. 54:256-259.
30. Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395-2400.
31. Monath, T. P., and F. X. Heinz. 1996. Flaviviruses, p. 961-1034. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
32. Mosier, D. E. 1990. Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases. J. Clin. Immunol. 10:185-191.
33. Mosier, D. E. 1996. Viral pathogenesis in hu-PBL-SCID mice. Semin. Immunol. 8:255-262.
34. Nimmannitya, S., U. Thisyakorn, and V. Hemsrichart. 1987. Dengue haemorrhagic fever with unusual manifestations. Southeast Asian J. Trop. Med. Public Health 18:398-406.
35. Patey, O., L. Ollivaud, J. Breuil, and C. Lafaix. 1993. Unusual neurologic manifestations occurring during dengue fever infection. Am. J. Trop. Med. Hyg. 48:793-802.
36. Pisa, P., E. Sitnicka, and M. Hansson. 1993. Activated natural killer cells suppress myelopoiesis in mice with severe combined immunodeficiency. Scand. J. Immunol. 37:529-532.
37. Porterfield, J. S. 1986. Antibody-dependent enhancement of viral infectivity. Adv. Virus Res. 31:335-355.
38. Rice, C. M. 1996. Flaviviridae: the viruses and their replication, p. 931-959. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
39. Row, D., P. Weinstein, and S. Murray-Smith. 1996. Dengue fever with encephalopathy in Australia. Am. J. Trop. Med. Hyg. 54:253-255.
40. Russel, P. K., and A. Nisalak. 1967. Dengue virus identification by the plaque reduction neutralisation test. J. Immunol. 99:291-296.
41. Sabin, A. B., and R. W. Schlesinger. 1945. Production of immunity to dengue with virus modified by propagation in mice. Science 101:640-642.
42. Schlesinger, R. W. 1977. Dengue viruses, p. 72-73. Springer-Verlag, New York, N.Y.
43. Sinniah, M., and A. Igarashi. 1995. Dengue haemorrhagic fever. Rev. Med. Virol. 5:193-203.
44. Wissman, C. L., Jr., B. H. Sweet, E. C. Rosenzweig, and O. R. Eylar. 1963. Attenuated living type 1 dengue vaccines. Am. J. Trop. Med. Hyg. 12:620-623.
45. Wu, S.-J. L., C. G. Hayes, D. R. Dubois, M. G. Windheuser, Y.-H. Kang, D. M. Watts, and D. G. Sieckmann. 1995. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am. J. Trop. Med. Hyg. 52:468-476.